Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec
- PMID: 37656261
- DOI: 10.1007/s10198-023-01625-3
Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec
Abstract
Background: The value of a Quality-Adjusted Life-Year (QALY) is of great importance for the healthcare system. It helps when it comes to defining a cost-effectiveness threshold for the evaluation of health technologies. No willingness-to-pay value for a QALY exists in the province of Quebec, Canada.
Objectives: In this paper, we empirically investigated the monetary value of a QALY for the population of Quebec.
Methods: Based on the Short-Form 6-Dimension version 2 (SF-6Dv2), we conducted an online survey with a representative adult sample living in Quebec. We used a time trade-off (TTO) combined with contingent valuation (CV), and a discrete choice experiment (DCE) to assess both the population's willingness to pay (WTP) for one QALY and the marginal WTP for health attributes. A health utility algorithm using hybrid regression was developed to determine a preference-based value set for health states.
Results: Main analysis was conducted on 993 answers for the CV and 2143 answers for the DCE. The willingness-to-pay per QALY varied from CA$ 47,048.84 (CI: 21,554.38; 72,543.30) for CV to CA$ 73,936.87 (CI: 63,105.40; 84,768.35) for DCE. Among the 6 dimensions of the SF-6Dv2, marginal WTP varied from CA$ 4499.15 (CI: 2975.06; 6023.25) for more role accomplishment in daily activities to CA$ 15,867.12 (CI: 13,825.75; 17,908.49) for less pain. Robustness check with multiple alternative samples, as well as alternative health utility algorithms, showed that the results were robust and the DCE method provided 50% larger results than the CV method, although confidence intervals overlap.
Conclusion: This paper provides useful information for decision-makers on the monetary value of a QALY in Quebec.
Keywords: Contingent valuation; Discrete choice experiment; QALY; Québec; SF-6Dv2; Time trade-off; WTP.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Mishan, E.J.: Cost-benefit analysis: an introduction. Praeger, New York (1971)
-
- Verbooy, K., Hoefman, R., van Exel, J., Brouwer, W.: Time is money: investigating the value of leisure time and unpaid work. Value in Health 21, 1428–1436 (2018). https://doi.org/10.1016/j.jval.2018.04.1828 - DOI - PubMed
-
- MSSS, Ministère de la Santé et des Services sociaux du Québec: Le système de santé et de services sociaux au Québec en bref. (2017). https://publications.msss.gouv.qc.ca/msss/fichiers/2017/17-731-01WF.pdf
-
- CADTH, Canadian Agency for Drugs and Technologies in Health: Guidelines for the Economic Evaluation of Health Technologies: Canada. 4th Edition (March 2017). https://www.cadth.ca/sites/default/files/pdf/guidelines_for_the_economic...
-
- HAS, Haute Autorité de Santé: Choix méthodologiques pour l’évaluation économique à la HAS. (Octobre 2011). https://www.has-sante.fr/upload/docs/application/pdf/2011-11/guide_metho...
MeSH terms
LinkOut - more resources
Full Text Sources